(Total Views: 438)
Posted On: 04/07/2017 4:49:50 PM
Post# of 15624
There's some confusion about the PR we had earlier in the week. That wasn't an "Efficacy Results" PR. If you think it was, re-read the opening sentence:
"announced it has received expressions of interest from the scientific and medical communities world-wide as a result of its recently announce positive preliminary clinical efficacy tests results of its topical cream to treat Psoriasis."
That PR was clearly more about the EXPRESSIONS OF INTEREST and then the mention of PRELIMINARY Clinical Efficacy Test Results.
So, that's why I said when the final trial finishes in April (likely, according to Dr. Baruch in that video interview), we could see the FINAL, FULL details PUBLISHED in the journal. Perhaps even the final "Patent Approval", since it's currently in the "PCT" stage of the progress.
"announced it has received expressions of interest from the scientific and medical communities world-wide as a result of its recently announce positive preliminary clinical efficacy tests results of its topical cream to treat Psoriasis."
That PR was clearly more about the EXPRESSIONS OF INTEREST and then the mention of PRELIMINARY Clinical Efficacy Test Results.
So, that's why I said when the final trial finishes in April (likely, according to Dr. Baruch in that video interview), we could see the FINAL, FULL details PUBLISHED in the journal. Perhaps even the final "Patent Approval", since it's currently in the "PCT" stage of the progress.
(0)
(0)
